Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Ketamine Offers Hope for OCD Patients as Alternative to Traditional Medication

Monroe, MI (Newsworthy.ai) Thursday Apr 27, 2023 @ 6:00 PM Central —

Ketamine is increasingly recognized as a promising treatment for those suffering from obsessive-compulsive disorder (OCD). With its ability to act on receptor sites in the brain, Ketamine Offers Hope for those individuals who have not seen success with traditional medication.

Ketamine has shown great promise in treating OCD symptoms by lifting the blockade that helps OCD symptoms develop and inhibits their progression. Ketamine also increases the levels of serotonin and dopamine receptors, which induces feelings of relaxation and relief from obsessive thoughts and behaviors."

Studies have shown that ketamine can reduce intrusive thoughts quickly, with many individuals experiencing positive results within hours of receiving a dose. In some cases, positive effects have lasted up to fourteen days after administration.

My K Blend knows that the use of ketamine in the treatment of OCD is a promising development and that ketamine therapy represents Hope for many people experiencing OCD symptoms.

About My K Blend

At K Blend, our experts will listen to your story. We will understand you. This relationship allows you to feel comfortable throughout the process and focus on healing.

Once you feel safe to heal, you can be honest. We don’t force you to wear a fake smile or pretend to be someone. Here, we are real, support you at your weakest, and lead you to hope, healing, and health.



This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.



This post first appeared on Newsworthy.ai News Marketing, please read the originial post: here

Share the post

Ketamine Offers Hope for OCD Patients as Alternative to Traditional Medication

×

Subscribe to Newsworthy.ai News Marketing

Get updates delivered right to your inbox!

Thank you for your subscription

×